Connexion
Connexion
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Inscription
Ou se connecter avec
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

RELIEF THERAPEUTICS HOLDING AG

(RLF)
  Rapport
Temps Différé Swiss Exchange  -  17:30 29/09/2022
0.0260 CHF   -3.35%
22/09Relief Therapeutics obtient l'approbation des États-Unis pour lancer un essai pilote pour le traitement d'une maladie de la peau
MT
22/09Relief Therapeutics Holding AG annonce l'approbation de l'IRB et le lancement d'un essai initié par un investigateur sur Nexodyn pour l'épidermolyse bulleuse à l'hôpital pour enfants Ann & Robert H. Lurie de Chicago
CI
15/09Relief Therapeutics Holding AG annonce ses résultats pour le semestre terminé le 30 juin 2022
CI
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFonds 
SynthèseToute l'actualitéAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur RELIEF THERAPEUTICS HOLDING AG
22/09Morning Briefing - Markt Schweiz
22/09Relief startet Studie mit Nexodyn zur Behandlung von Hautkrankheit
22/09Relief Therapeutics Gets US Approval to Launch Pilot Trial For Skin Disease Treatment
22/09Relief Therapeutics Holding AG Announces IRB Approval and Initiation of an Investigator..
22/09Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated ..
15/09Relief Therapeutics Holding AG Reports Earnings Results for the Half Year Ended June 30..
15/09Relief Therapeutics hat Verlust im H1 wegen höherer Kosten fast verdoppelt
15/09Relief Therapeutics Posts Wider Attributable Loss In H1
15/09Relief Reports Half-Year 2022 Results and Provides Corporate Update
12/09Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum
07/09Relief Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment..
24/08Morning Briefing - Markt Schweiz
24/08Relief Therapeutics will Beteiligungspapiere ADS an Nasdaq kotieren lassen
24/08Switzerland's Relief Therapeutics Seeks To List American Depositary Shares On NASDAQ
24/08Relief Therapeutics files registration statement on form F-1 with the U.S. Securities a..
23/08Relief Therapeutics Holding AG has filed an IPO.
22/08NRx Pharmaceuticals, Relief Therapeutics Reach Tentative Settlement Over Zyesami Litiga..
22/08Relief Therapeutics legt Rechtsstreit mit US-Partner NRx vorläufig bei
22/08Relief Therapeutics, NRx Pharmaceuticals Secure Tentative Settlement Over Aviptadil Dis..
22/08Relief Therapeutics Holding SA and NRx Pharmaceuticals, Inc. announce tentative settlem..
17/08Morning Briefing - Markt Schweiz
17/08Relief Therapeutics ernennt David McCullough zum Head of U.S. Market Access
17/08Relief Therapeutics Appoints David McCullough as Head of U.S. Market Access
17/08Relief Therapeutics Holding SA Appoints David McCullough as Head of U.S. Market Access,..
15/08Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Gra..
12/08Acer Therapeutics, Relief Therapeutics Say EU Grants Orphan Drug Designation to ACER-00..
12/08RELIEF THERAPEUTICS Holding SA and Acer Therapeutics Inc. Announce That the European Co..
12/08Relief und Acer erhalten "Orphan Drug Status" in EU für Stoffwechsel-Kandidaten
12/08Relief Therapeutics Partner Acer Gets EU Orphan Drug Designation For Maple Syrup Urine ..
12/08Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Gra..
04/08Relief Therapeutics : Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance fo..
04/08Relief Therapeutics Holding Ag Announces U.S. Food and Drug Administration Accepts for ..
03/08Morning Briefing - Markt Schweiz
03/08Relief Therapeutics' New Formulation For Lung Disease Drug Shows Clinical Significant I..
03/08Relief Therapeutics : Announces Promising Initial Stability Data on a New Formulation of R..
03/08Relief Therapeutics Announces Promising Initial Stability Data on a New Formulation of ..
28/07Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Review of NDA Res..
28/07Acer Therapeutics : FDA Accepts Resubmitted NDA for ACER-001
28/07Relief-Partner Acer kommt mit erneutem US-Zulassungsantrag für ACER-001 weiter
28/07Relief Partner Acer Makes Investigational New Drug Submission For Maple Syrup Urine Dis..
28/07Relief Therapeutics Partner's Application for Metabolism Disorder Drug Accepted for US ..
28/07Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Trea..
28/07Acer Therapeutics and Relief Therapeutics Announce FDA Acceptance for Review of NDA Res..
28/07Acer Therapeutics and Relief Therapeutics Announces ACER-001 IND Submission for the Tre..
21/07Morning Briefing - Markt Schweiz
21/07Relief Therapeutics einen Schritt weiter bei Nasdaq-Kotierung
21/07Relief Therapeutics Announces Effectiveness of Registration Statement on Form 20-F
18/07Acer Therapeutics Resubmits FDA Application for ACER-001
18/07Relief-Partner Acer reicht US-Zulassungsantrag für ACER-001 erneut ein
18/07Relief Therapeutics Partner Acer Resubmits New Drug Application To US FDA For Urea Cycl..
18/07Relief Therapeutics Announces that its Collaboration Partner has Resubmitted the ACER-0..
18/07Relief Therapeutics Appoints Serene Forte, Ph.D., MPH, as Senior Vice President, Head o..
18/07Relief Therapeutics Appoints Serene Forte, Ph.D., MPH, as Senior Vice President, Head o..
13/07Relief-Tochter APR erwirbt neue Darreichungsform zur Behandlung von PKU
13/07Relief Therapeutics Unit To Acquire Commercialization Rights For Phenylketonuria Treatm..
13/07Relief Signs a Definitive Agreement to Acquire a Novel Dosage Form of an Already Approv..
11/07Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual..
08/07Acer Therapeutics, Relief Therapeutics Receive Chinese Patent for Urine Disease Drug Ca..
08/07Relief und Partner Acer erhalten Patent für ACER-001 in China
08/07Relief Therapeutics, Partner Acer Win Chinese Patent For ACER-001 Dosage Form
08/07Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual..
04/07Relief Therapeutics Partner NRx Receives US FDA's Emergency Use Rejection For Aviptadil
04/07Relief Therapeutics Files Amendment No. 4 to its Registration Statement on Form 20-F wi..
04/07Relief Reports that its U.S. Collaboration Partner has Announced that the FDA has Decli..
01/07Relief-Partner NRx scheitert mit US-Antrag auf Notfallzulassung für Zyesami
24/06Aktien Schweiz: SMI zieht zum Wochenschluss deutlich an
21/06Acer Therapeutics Shares Hit 52-Week Low After FDA Rejects ACER-001
21/06Relief Therapeutics, Acer's New Drug Application For Urea Cycle Disorders Drug Rejected..
21/06Relief und Partner Acer erleiden Rücksetzer mit US-Zulassungsantrag
21/06Acer Therapeutics : FDA Rejects ACER-001 Application
21/06Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Dru..
21/06Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Dru..
21/06Acer Therapeutics and Relief Therapeutics Announce Update on U.S. FDA Review of New Dru..
17/06Relief Therapeutics Files Amendment No. 3 to its Registration Statement on Form 20-F wi..
13/06Relief-Partner NRx scheitert mit US-Antrag auf Therapiedurchbruch für Aviptadil
13/06US FDA Rejects Relief Therapeutics Partner NRx's Breakthrough Request For Zyesami
13/06Relief Reports that its U.S. Collaboration Partner has Announced an Update on Breakthro..
08/06Relief Therapeutics muss länger auf FDA-Entscheid zu Acer-001 warten
08/06Relief Therapeutics' Collaboration Partner Acer Therapeutics Awaits US FDA Nod On Urea ..
08/06Relief Reports that its Collaboration Partner, Acer Therapeutics, Issued a Statement Re..
01/06Relief Therapeutics Announces Results of Annual General Meeting of RELIEF THERAPEUTICS ..
31/05US-Studie mit Relief-Kandidat Aviptadil wird wegen Aussichtslosigkeit gestoppt
31/05Relief Therapeutics To Continue Developing Aviptadil For Other Indications After US Hal..
31/05Relief Provides a Corporate Update and Comments on the Recently Announced DSMB Update o..
27/05Aktien Schweiz: Positiver Wochenabschluss in Sicht
26/05Relief: Datenüberwachungskomitee empfielt Einstellung der Aviptadil-Studien
26/05Relief Therapeutics' Partners Receives Review For COVID-19 Drug Trial
26/05Relief Reports that its U.S. Collaboration Partner Announces Data Safety Monitoring Boa..
23/05Relief Therapeutics erweitert US-Vertriebsteam
23/05Relief Therapeutics Expands U.S. Commercial Team
23/05Relief Therapeutics Expands U.S. Commercial Team
11/05Relief Therapeutics Files Amendment No. 2 to its Registration Statement on Form 20-F wi..
09/05Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the..
09/05Relief Therapeutics to Participate in Industry and Investor Conferences in May
06/05Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the..
06/05Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the..
06/05Acer Therapeutics Inc. and Relief Therapeutics Holding AG Announce Presentation of Acer..
06/05Relief Therapeutics Announces Notice of Annual General Meeting of RELIEF THERAPEUTICS H..
27/04Relief-Tochter APR erhält US-Patent für Nahrungsergänzungsmittel
27/04Relief Therapeutics Unit Secures Notice Of Allowance For Patent Claims Covering Amino A..
Prochain événement sur RELIEF THERAPEUTICS HOLDING AG